In order to participate in the selection process, please submit your abstract within 10 March 2026
The most outstanding abstracts will have the opportunity to be presented orally during the round tables with a 10-minute talk followed by 5 minutes for questions.
SUBMISSION RULES
Please see the guidelines for writing your abstract below:
Before you begin, please prepare the following information:
- Title, authors, affiliation:
- Title (Lowercase, Bold, minimum 15, maximum 300 characters)
- Authors (first names, middle initials, and last names) separated by a comma
- Affiliations (Institution, Town, Country)
- Abstract text is limited to 400 words.
- The abstract should be divided into sections:
- Background
- Methods
- Results
- Conclusion/Acknowledgements
- Only one table, graph, or figure is allowed; it should be included in one of the following formats: .pdf, .xlsx, .docx, .xls, .doc, .ods, or .odt (maximum size 6MB).
- Abstract topics: Please select your topic after consulting the list of topics listed below:
- Neuroimmunology Insights;
- Lymphocyte Response Dysregulation in Autoimmune Diseases
- Border Control in CNS Diseases
- New & Views from Neurological Diseases
- Myasthenia Gravis and Other Autoimmune diseases
- Neuroscience Research in Space
- Regenerative Neuroimmunology
- Emerging Biomarkers in Demyelinating CNS Disorders
- All abstracts must be submitted and presented in clear English with accurategrammar and spelling of a quality suitable for publication.
- Any abbreviations should be defined where first mentioned.
- Responsibility for the accuracy and completeness of the abstract rests entirely with the authors. Accepted abstracts will be printed as submitted.
- Abstracts that do not adhere to the specifications mentioned above will be returned.
